Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Norway Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20151
20171
20181
20202
20211
20222
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chugai Pharmaceutical2
Ostfold Hospital Trust2
Principia Biopharma, a Sanofi Company2
Rigel Pharmaceuticals2
argenx2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Eli Lilly and Company1
European Research Consortium on ITP1
Hutchmed1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic17
Thrombocytopenia3
Antiphospholipid Syndrome2
Autoimmune Diseases2
Behcet Syndrome2
Blood Platelet Disorders2
Dermatomyositis2
Hematologic Diseases2
Hemorrhage2
Hemorrhagic Disorders2

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.